Choline bitartrate Market By Type (DL, D, L), By Application (Pharmaceutical and Nutritional Supplement, Food and beverage, Baby Food, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

PUBLISHED: June 1, 2022

PAGES: 255 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The global choline bitartrate market was valued at $410.2 million in 2021, and is projected to reach $736.2 million by 2031, registering a CAGR of 6.1% from 2022 to 2031.

Choline bitartrate is an active pharmaceutical ingredient produced from a mixture of tartaric acid and choline. It has a better absorption rate than pure choline and is widely available in two different types such choline l-bitartrate and choline dl-bitartrate. It plays a crucial role in lipid transportation, healthy metabolism, supports cell membrane, DNA synthesis, and early brain development. It is utilized in producing organic and fortified organic baby foods as they enhance visuospatial memory in a child. It is used in various health-related problem and is widely used in poultry and animal feed, baby food, pharmaceutical & nutritional supplement, and food & beverage.

In recent years, there is rising demand for infant formula due to the surge in the baby boomers population, rapid urbanization, rising disposable income of people in developing countries, and increasing female participation in the labor force. According to Vitafoods Insights, infant formula sales is predicted to witness substantial growth via e-commerce, and starting milk formulas are anticipated to hold around 45% of global demand. Infant formula sales will continue to grow due to its growing acceptance as a viable breastmilk alternative. Further, during 2019-2026, the global infant formula market is projected for noteworthy growth at a 10% CAGR. Moreover, according to Agricultural Marketing Service U.S. DEPARTMENT OF AGRICULTURE (AMS USDA), choline salts are allowable in infant formula in Canada, listed under Division 25 (B.25.054(1)(a)(vii)) of the Food and Drug Regulations. Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to Organic Production Systems General Principles and Management Standards (CAN/CGSB-32.310-2006) and Organic Production Systems Permitted Substances List (CAN/CGSB-32.311-2006). Further, choline salts are an acceptable form of choline in infant formula and baby food in European Union, according to Commission Directive 2006/141/EC, Commission Directive 2006/125/EC. They are also allowed in the category of "foods for particular nutritional uses" (Commission Regulation 953/2009, Commission Directive 2009/39/EC). Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to European Commission Regulation 889/2008. Thus, the growing demand for infant formula is anticipated to propel the demand for choline bitartrate during the forecast period. However, growing inclination towards natural food products and stringent regulation for manufacturing infant formula may hamper the steady growth of the market. Nonetheless, the growing use of choline bitartrate in healthcare to treat numerous diseases and its use in poultry and animal feed is anticipated to create lucrative opportunities for the growth of the choline bitartrate market.

The choline bitartrate market is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products. Further, the rise in sales of dietary supplements owing to the hectic routines and stress level of the consumers is anticipated to propel the choline bitartrate market growth during the forecast period.

The key players operating in the global choline bitartrate market include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co.,Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co.,Ltd; NutriScience Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. These companies compete for the share of the market through product launch, joint venture, partnership, and expansion of the production capabilities to meet the future demand for the choline bitartrate market during the forecast period.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the choline bitartrate market analysis from 2021 to 2031 to identify the prevailing choline bitartrate market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the choline bitartrate market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global choline bitartrate market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

By Application

Baby Food
Others
Pharmaceutical and Nutritional Supplement
Food and beverage

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Rest of LAMEA
- Brazil
- Saudi Arabia
- South Africa
Key Market Players
- Balchem Inc.
- Celtic Chemicals Ltd
- Cepham Life Sciences
- Fengchen Group Co.,Ltd
- Glentham Life Sciences Ltd
- MP Biomedicals
- Nutragreenlife Biotechnology Co.,Ltd
- NutriScience Innovations, LLC
- Puyer Group
- TOKYO CHEMICAL INDUSTRY CO., LTD.

Product Code: A17003

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape
3.8.Value Chain Analysis

CHAPTER 4: CHOLINE BITARTRATE MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 DL
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 D
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 L
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country

CHAPTER 5: CHOLINE BITARTRATE MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Pharmaceutical and Nutritional Supplement
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Food and beverage
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Baby Food
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country

CHAPTER 6: CHOLINE BITARTRATE MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Type
- 6.2.3 North America Market size and forecast, by Application
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Market size and forecast, by Type
  - 6.2.4.1.2 Market size and forecast, by Application
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Market size and forecast, by Type
  - 6.2.4.2.2 Market size and forecast, by Application
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Market size and forecast, by Type
  - 6.2.4.3.2 Market size and forecast, by Application
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Type
- 6.3.3 Europe Market size and forecast, by Application
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Market size and forecast, by Type
  - 6.3.4.1.2 Market size and forecast, by Application
  - 6.3.4.2 France
  - 6.3.4.2.1 Market size and forecast, by Type
  - 6.3.4.2.2 Market size and forecast, by Application
  - 6.3.4.3 U.K.
  - 6.3.4.3.1 Market size and forecast, by Type
  - 6.3.4.3.2 Market size and forecast, by Application
  - 6.3.4.4 Spain
  - 6.3.4.4.1 Market size and forecast, by Type
  - 6.3.4.4.2 Market size and forecast, by Application
  - 6.3.4.5 Italy
  - 6.3.4.5.1 Market size and forecast, by Type
  - 6.3.4.5.2 Market size and forecast, by Application
  - 6.3.4.6 Rest of Europe
  - 6.3.4.6.1 Market size and forecast, by Type
  - 6.3.4.6.2 Market size and forecast, by Application
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Type
- 6.4.3 Asia-Pacific Market size and forecast, by Application
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Market size and forecast, by Type
  - 6.4.4.1.2 Market size and forecast, by Application
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Market size and forecast, by Type
  - 6.4.4.2.2 Market size and forecast, by Application
  - 6.4.4.3 India
  - 6.4.4.3.1 Market size and forecast, by Type
  - 6.4.4.3.2 Market size and forecast, by Application
  - 6.4.4.4 South Korea
  - 6.4.4.4.1 Market size and forecast, by Type
  - 6.4.4.4.2 Market size and forecast, by Application
  - 6.4.4.5 Australia
  - 6.4.4.5.1 Market size and forecast, by Type
  - 6.4.4.5.2 Market size and forecast, by Application
  - 6.4.4.6 Rest of Asia-Pacific
  - 6.4.4.6.1 Market size and forecast, by Type
  - 6.4.4.6.2 Market size and forecast, by Application
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Type
- 6.5.3 LAMEA Market size and forecast, by Application
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Market size and forecast, by Type
  - 6.5.4.1.2 Market size and forecast, by Application
  - 6.5.4.2 Saudi Arabia
  - 6.5.4.2.1 Market size and forecast, by Type
  - 6.5.4.2.2 Market size and forecast, by Application
  - 6.5.4.3 South Africa
  - 6.5.4.3.1 Market size and forecast, by Type
  - 6.5.4.3.2 Market size and forecast, by Application
  - 6.5.4.4 Rest of LAMEA
  - 6.5.4.4.1 Market size and forecast, by Type
  - 6.5.4.4.2 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments

CHAPTER 8: COMPANY PROFILES

8.1 Balchem Inc.
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
8.2 Celtic Chemicals Ltd
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
8.3 Cepham Life Sciences
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
8.4 Fengchen Group Co.,Ltd
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
8.5 Glentham Life Sciences Ltd
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
8.6 MP Biomedicals
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
8.7 Nutragreenlife Biotechnology Co.,Ltd
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
8.8 NutriScience Innovations, LLC
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
8.9 Puyer Group
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
8.10 TOKYO CHEMICAL INDUSTRY CO., LTD.
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments

Product Code: A17003

LIST OF TABLES

TABLE 1. GLOBAL CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. CHOLINE BITARTRATE MARKET SIZE, FOR DL, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CHOLINE BITARTRATE MARKET FOR DL BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. CHOLINE BITARTRATE MARKET SIZE, FOR D, BY REGION, 2021-2031 ($MILLION)
TABLE 5. CHOLINE BITARTRATE MARKET FOR D BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. CHOLINE BITARTRATE MARKET SIZE, FOR L, BY REGION, 2021-2031 ($MILLION)
TABLE 7. CHOLINE BITARTRATE MARKET FOR L BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. GLOBAL CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 9. CHOLINE BITARTRATE MARKET SIZE, FOR PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 10. CHOLINE BITARTRATE MARKET FOR PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. CHOLINE BITARTRATE MARKET SIZE, FOR FOOD AND BEVERAGE, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CHOLINE BITARTRATE MARKET FOR FOOD AND BEVERAGE BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. CHOLINE BITARTRATE MARKET SIZE, FOR BABY FOOD, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CHOLINE BITARTRATE MARKET FOR BABY FOOD BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. CHOLINE BITARTRATE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. CHOLINE BITARTRATE MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. CHOLINE BITARTRATE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. U.S. CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 22. U.S. CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 23. CANADA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 24. CANADA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 25. MEXICO CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. MEXICO CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. EUROPE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 28. EUROPE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 29. EUROPE CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. GERMANY CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 31. GERMANY CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. FRANCE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 33. FRANCE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. U.K. CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. U.K. CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. SPAIN CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 37. SPAIN CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. ITALY CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. ITALY CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. REST OF EUROPE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. REST OF EUROPE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 42. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 43. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. CHINA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. CHINA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. JAPAN CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. JAPAN CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. INDIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. INDIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. SOUTH KOREA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 52. SOUTH KOREA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. AUSTRALIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. AUSTRALIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. LAMEA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. LAMEA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. LAMEA CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 60. BRAZIL CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. BRAZIL CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. SAUDI ARABIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 63. SAUDI ARABIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. SOUTH AFRICA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 65. SOUTH AFRICA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. REST OF LAMEA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. REST OF LAMEA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68.BALCHEM INC.: COMPANY SNAPSHOT
TABLE 69.BALCHEM INC.: OPERATING SEGMENTS
TABLE 70.BALCHEM INC.: PRODUCT PORTFOLIO
TABLE 71.BALCHEM INC.: NET SALES,
TABLE 72.BALCHEM INC.: KEY STRATERGIES
TABLE 73.CELTIC CHEMICALS LTD: COMPANY SNAPSHOT
TABLE 74.CELTIC CHEMICALS LTD: OPERATING SEGMENTS
TABLE 75.CELTIC CHEMICALS LTD: PRODUCT PORTFOLIO
TABLE 76.CELTIC CHEMICALS LTD: NET SALES,
TABLE 77.CELTIC CHEMICALS LTD: KEY STRATERGIES
TABLE 78.CEPHAM LIFE SCIENCES: COMPANY SNAPSHOT
TABLE 79.CEPHAM LIFE SCIENCES: OPERATING SEGMENTS
TABLE 80.CEPHAM LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 81.CEPHAM LIFE SCIENCES: NET SALES,
TABLE 82.CEPHAM LIFE SCIENCES: KEY STRATERGIES
TABLE 83.FENGCHEN GROUP CO.,LTD: COMPANY SNAPSHOT
TABLE 84.FENGCHEN GROUP CO.,LTD: OPERATING SEGMENTS
TABLE 85.FENGCHEN GROUP CO.,LTD: PRODUCT PORTFOLIO
TABLE 86.FENGCHEN GROUP CO.,LTD: NET SALES,
TABLE 87.FENGCHEN GROUP CO.,LTD: KEY STRATERGIES
TABLE 88.GLENTHAM LIFE SCIENCES LTD: COMPANY SNAPSHOT
TABLE 89.GLENTHAM LIFE SCIENCES LTD: OPERATING SEGMENTS
TABLE 90.GLENTHAM LIFE SCIENCES LTD: PRODUCT PORTFOLIO
TABLE 91.GLENTHAM LIFE SCIENCES LTD: NET SALES,
TABLE 92.GLENTHAM LIFE SCIENCES LTD: KEY STRATERGIES
TABLE 93.MP BIOMEDICALS: COMPANY SNAPSHOT
TABLE 94.MP BIOMEDICALS: OPERATING SEGMENTS
TABLE 95.MP BIOMEDICALS: PRODUCT PORTFOLIO
TABLE 96.MP BIOMEDICALS: NET SALES,
TABLE 97.MP BIOMEDICALS: KEY STRATERGIES
TABLE 98.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: COMPANY SNAPSHOT
TABLE 99.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: OPERATING SEGMENTS
TABLE 100.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: PRODUCT PORTFOLIO
TABLE 101.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: NET SALES,
TABLE 102.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: KEY STRATERGIES
TABLE 103.NUTRISCIENCE INNOVATIONS, LLC: COMPANY SNAPSHOT
TABLE 104.NUTRISCIENCE INNOVATIONS, LLC: OPERATING SEGMENTS
TABLE 105.NUTRISCIENCE INNOVATIONS, LLC: PRODUCT PORTFOLIO
TABLE 106.NUTRISCIENCE INNOVATIONS, LLC: NET SALES,
TABLE 107.NUTRISCIENCE INNOVATIONS, LLC: KEY STRATERGIES
TABLE 108.PUYER GROUP: COMPANY SNAPSHOT
TABLE 109.PUYER GROUP: OPERATING SEGMENTS
TABLE 110.PUYER GROUP: PRODUCT PORTFOLIO
TABLE 111.PUYER GROUP: NET SALES,
TABLE 112.PUYER GROUP: KEY STRATERGIES
TABLE 113.TOKYO CHEMICAL INDUSTRY CO., LTD.: COMPANY SNAPSHOT
TABLE 114.TOKYO CHEMICAL INDUSTRY CO., LTD.: OPERATING SEGMENTS
TABLE 115.TOKYO CHEMICAL INDUSTRY CO., LTD.: PRODUCT PORTFOLIO
TABLE 116.TOKYO CHEMICAL INDUSTRY CO., LTD.: NET SALES,
TABLE 117.TOKYO CHEMICAL INDUSTRY CO., LTD.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.CHOLINE BITARTRATE MARKET SEGMENTATION
FIGURE 2.CHOLINE BITARTRATE MARKET,2021-2031
FIGURE 3.CHOLINE BITARTRATE MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CHOLINE BITARTRATE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PATENT ANALYSIS BY COMPANY
FIGURE 13.PATENT ANALYSIS BY COUNTRY
FIGURE 14.VALUE CHAIN ANALYSIS
FIGURE 15.CHOLINE BITARTRATE MARKET,BY TYPE,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DL CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF D CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF L CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 19.CHOLINE BITARTRATE MARKET,BY APPLICATION,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF FOOD AND BEVERAGE CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BABY FOOD CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS CHOLINE BITARTRATE MARKET,2021-2031(%)
FIGURE 24.CHOLINE BITARTRATE MARKET BY REGION,2021
FIGURE 25.U.S. CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 26.CANADA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 27.MEXICO CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 28.GERMANY CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 29.FRANCE CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 30.U.K. CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 31.SPAIN CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 32.ITALY CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 34.CHINA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 35.JAPAN CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 36.INDIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 37.SOUTH KOREA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 38.AUSTRALIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 39.REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 40.BRAZIL CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 41.SAUDI ARABIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 42.SOUTH AFRICA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 43.REST OF LAMEA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48.COMPETITIVE DASHBOARD
FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 50.BALCHEM INC..: NET SALES ,($MILLION)
FIGURE 51.CELTIC CHEMICALS LTD.: NET SALES ,($MILLION)
FIGURE 52.CEPHAM LIFE SCIENCES.: NET SALES ,($MILLION)
FIGURE 53.FENGCHEN GROUP CO.,LTD.: NET SALES ,($MILLION)
FIGURE 54.GLENTHAM LIFE SCIENCES LTD.: NET SALES ,($MILLION)
FIGURE 55.MP BIOMEDICALS.: NET SALES ,($MILLION)
FIGURE 56.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD.: NET SALES ,($MILLION)
FIGURE 57.NUTRISCIENCE INNOVATIONS, LLC.: NET SALES ,($MILLION)
FIGURE 58.PUYER GROUP.: NET SALES ,($MILLION)
FIGURE 59.TOKYO CHEMICAL INDUSTRY CO., LTD..: NET SALES ,($MILLION)